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Summan- The atypical mole syndrome (AMS) phenotype. characterised by a large number of common naeVi
as well as atypical naeVi. has been described in families With a genetic susceptibility to melanoma. However. the
importance of this phenotype for melanoma in the general population has not been conclusively determined.
This study was designed to examine the types and distribution of naeVi as well as the prevalence of the AMS
phenotype in melanoma patients in England compared with controls. A total of 426 cutaneous melanoma cases
(610o of all incident cases) aged 16-75 years were recruited between 1989 and 1993 from the north-east
Thames region of the UK and 416 controls from the same age group were recruited over the same period and
from the same region. Each subject answered a questionnaire cosering demographic details. sun exposure
history- and other risk factors and underwent a skin examination with total body naevus count performed by a
dermatologist. The AMS phenotype was defined using a scoring system. Atypical naevi gave the highest relatisve
risk for cutaneous melanoma, with an odds ratio (OR) of 28.7 (P<0.0001) for four or more atypical naevi
compared with none. Many common naevi were also an important risk factor: the OR for 100 or more naevi
2 mm or above in diameter compared with 0-4 naeVi was 7.7 (P<0.0001). Melanoma was also associated with
neavi on sun-exposed sites but also with naevi on non-sun-exposed sites such as the dorsum of the feet.
buttocks and anterior scalp. Sixteen per cent of the cases had the AMS phenotype compared with 2% of the
controls (OR 10.4. P<0.0001). The AMS phenotype was more common in males than females (P=0.008). The
odds ratio for the presence of the AMS phenotype was dependent on age. with an odds ratio of 16.1 (9500 CI
4.6-57.5) for the presence of the AMS phenotype if aged less than 40 compared with an odds ratio of 6.9
(95% CI 2.9-16.6) if aged 40 or more. The AMS phenotype was strongly predictive of an increased risk of
melanoma outside the familial context.
Kevwords-. melanoma: case-control study: atypical naevi: atypical mole syndrome
Melanoma incidence is rising in Caucasian populations
(Coleman et al.. 1993). Solar radiation plays a role in the
aetiology of melanoma (Koh et al., 1990; IARC. 1992). Host
factors are also important and individuals with fair hair and
skin are more at risk of melanoma. but the magnitude of the
odds ratio associated with a fair complexion is only of the
order of 2 to 3 (Bliss et al.. 1995). Case-control studies of
melanoma focusing on the naevus phenotype have established
that large numbers of naevi as well as atypical naevi are the
most important risk factors yet found, With odds ratios of the
order of 10 or more for 100 or more common naeVi
(Swerdlow et al.. 1986: Holly et al.. 1987; Grob et al..
1990). However, the magnitude of the odds ratios associated
with common or atypical naevi varies greatly between these
studies (Swerdlow et al., 1986: Grob et al.. 1990: Holly et al..
1987; Augustsson et al.. 1991: Garbe et al.. 1994). This might
be related to differences in the naevus count protocols or to
differences between populations. Few studies have formally
investigated the types and distribution of naevi on different
body sites.
The Atypical Mole Syndrome (AMS) is a well recognised
naevus phenotype mostly described in families with a genetic
susceptibility to melanoma (Clark et al.. 1978: Greene et al..
1985; Albert et al.. 1990). This phenotype. which has also
been described sporadically in individuals with no family
history ofmelanoma (Halpern et al.. 1991) is characterised by
large number of naevi, atypical naevi as well as naevi on non-
sun-exposed sites (Tucker et al.. 1983: Newton et al.. 1994).
In melanoma families. this phenotype is strongly predictive of
an increased melanoma nrsk. but the predictive value of the
phenotype in population-based melanoma cases has not been
fully examined. This present case-control study investigated
the numbers. types and distribution of naevi in melanoma
cases and controls. with naevus counts performed by two
dermatologists. The prevalence of the AMS phenotype in
these cases and controls was also determined. The main aim
was to determine which naeuvs phenotype is the most
predictive of melanoma.
Methods
All incident cases of cutaneous melanoma diagnosed at ages
16 -75 years. between August 1989 and August 1993. resident
in the north-east Thames region of England at the time of
their diagnosis were ascertained from pathology reports from
NHS and private hospitals within the region. As a form of
cross-check. the respective consultants from dermatology and
surgery departments were asked to provide us regularly with
a list of the melanoma cases recently diagnosed. Pathology
departments from hospitals just outside the boundary of the
region were also approached to detect cases living within the
area who were being referred outside the region. Histologi-
cally all melanomas (superficial spreading. nodular. lentigo
maligna and acral lentiginous as well as melanoma in situ)
were included in the study. A total of 694 eligible cases were
ascertained from pathology reports within the region over the
4 year period. Two hundred and sixty-eight of these cases
were not included: 67 because of consultant refusal. 181
because of patient refusal or failure to replv to several letters
and 20 because they had died. In all. 426 (610% of all eligible
cases) cases were included in the study [255 (60%) females
and 171 (40%) males].
The 416 controls [253 (610%) females and 163 (39%) males]
in this study comprised 282 hospital outpatients and 134
from general practice surgeries within the same region as the
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cases. Although individual matching was not performed, care
was taken throughout the study period to have an
approximate frequency matching for age and sex. The 282
hospital controls were recruited from three hospitals within
the north-east Thames region: the Royal London Hospital,
Whitechapel, St Margaret's Hospital, Epping, and St
Andrew's Hospital, Billericay (these hospitals were selected
as they were those from which most of the cases came). The
controls were recruited from the outpatient clinics in
gastroenterology, ENT, cardiology, surgery and orthopae-
dics (with diagnoses other than malignancies). Additionally,
patients from dermatology outpatients with skin conditions
not known to be associated with sun exposure such as viral
warts were eligible. For the 134 controls recruited from
general practice waiting areas, patients attending for
conditions other than skin disease, malignancy or other
chronic disease and their spouses were eligible. There were
very few refusals to take part among the controls (less than
5%). The two groups of controls had a similar distribution of
all characteristics of naevi, and therefore all results will be
given for the pooled control group.
Cases and controls were interviewed by one of two
research nurses (EP or KG) or one of two dermatologists
(JNB or VB). As the nurses and dermatologists were aware of
the case-control status, the structured questionnaire was
designed to ensure that the interviewer worded the questions
the same way for cases and controls. It was impossible to be
blind to the case-control status in view of the scar left
following melanoma excision. Cases were interviewed
following a letter inviting them to attend the research clinic.
Controls were interviewed immediately after being recruited
in waiting areas. Examinations for both cases and controls
took place straight after the interview. JNB performed the
total body mole count in 66% of the cases and 56% of the
controls and the remainder of the counts was performed by
VB. The individuals' past occupations and the current
occupations of their partners were obtained by interview:
social class was defined to be that associated with the most
skilled of the occupations of either partner.
Hair and eye colour were recorded. The skin types were
assessed using the Fitzpatrick classification: type 1, always
burn and never tan; type 2, burn and tan slightly; type 3,
burn moderately, tan gradually; type 4, rare burn, tan deeply
(Fitzpatrick, 1988). All cutaneous naevi greater than or equal
to 2 mm in diameter were counted except on genitalia, female
breasts and posterior scalp. Melanocytic naevi were recorded
according to size (2-4 mm, 5-9 mm, > 10 mm) and clinical
features (irregular border and pigment) for each of 17 body
areas. Pigmented lesions of the iris of the any size were also
recorded. Clinically atypical, congenital and blue naevi were
recorded separately. A naevus at least 5 mm in diameter with
irregular pigmentation and an irregular or hazy border was
defined to be clinically atypical. The total body naevus count
included all naevi greater than or equal to 2 mm in diameter,
the majority of which were common naevi (see footnote to
Table VI).
The AMS phenotype was defined using our AMS scoring
system (Newton et al., 1994). The individual was considered
affected if he or she exhibited at least three of the five clinical
features.
Case-control comparisons were analysed using uncondi-
tional logistic regression adjusted for age, sex and examiner.
Confidence intervals (95%) and significance levels were based
on an asymptotic normal approximation to the Wald test. All
odds ratios presented have been adjusted for the potential
confounding effects of age, examiner and sex (except for the
sex-specific analyses). Further adjustment for social class, hair
and eye colour made no difference and these adjustments are
not shown. Chi-squared tests for trend were based on the
likelihood ratio and had one degree of freedom. Trend tests
did not include a separate intercept parameter and were
based on linear scoring of the groups shown in the tables.
The attributable proportion of disease in the population due
to exposure was calculated from estimated relative risks and
the proportion of cases; confidence intervals were based on
the formula for the variance of the logarithm of the
attributable proportion given by Greenland (1987).
Results
Histological subtype, site and thickness ofmelanomas
The majority of the melanomas were of the superficial
spreading type (SSM) (60%), with nodular melanoma (NM)
and lentigo maligna (LM) representing 16% and 6% of the
cases respectively. Melanoma was found most commonly on
the legs (33%), with the back as the second most common
site (22%). Forty-nine per cent of melanomas were below
0.75 mm in thickness while 11% were 3 mm or above in
thickness (thickness was available for 300 eligible cases). Four
melanoma cases had a positive family history of melanoma
affecting a first or second degree relative.
Age, social class, skin type, hair and eye colour
Forty per cent (171) of the cases were male compared with
39% (163) of the controls (X21=0.1 P=0.8). There were
more controls in the younger age groups; 23% of the cases
were aged 40 years or under compared with 39% of the
controls. The distribution of social class was comparable
between cases and controls (X25=9.1, P=0.1) with 39% of
the cases in social class 1 and 2 compared with 47% of the
controls. A total of49% ofthe cases and 44% ofthe controls
belonged to social classes 3 and 4. Red and blonde hair were
more common among cases than controls, with a significant
increase in risk of melanoma for persons with red hair (OR
2.5, 95% CI 1.5-4.2 relative to dark brown hair). Cases were
more likely to have blue eyes than brown eyes, but the
association with blue eyes was not significant (OR 1.6, 95%
CI 0.8-3.3 relative to brown eyes). Skin type 1 was more
common in cases than controls, with an odds ratio of 9.1
(95% CI 3.8-21.6) compared with skin type 4. A highly
significant trend in risk was found by skin type (Table I).
Whole body naevus count (>2 mm in diameter)
Cutaneous melanoma risk was related to the number of naevi
, 2 mm in diameter, with a highly significant trend for
increasng numbers of naevi (P<0.0001) (Table II). In all
18% of the cases had 100 or more naevi of 2 mm in diameter
Tabke I Risk of melanoma in relation to skin types (Fitzpatrick's classification)
Cases Controls
Skin tipes No. (%) No. (%) OR] (95% CI) OR2 (95% CI)
I 53 (12) 18 (4) 9.1 (3.8-21.6)*** 11.2 (4.3-38.7)***
II 121 (28) 93 (22) 4.0 (1.9-8.4)*** 4.1 (1.0*-9.1)***
III 241 (57) 267 (64) 2.8 (1.4-5.6) ** 2.9 (1.4-6.3) **
IV 11 (3) 34 (8) 1.0 1.0 1.0
*P<0.05. **P<0.01. ***P<0.001. ORI adjusted for age, sex andexaminer. Trend testX21 =25.1, P<0.0001. OR2 further
adjusted for whole body naevus count. Trend test X21 =25.4 P<0.0001.Risk of cu ulanorm
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Table II Risk of melanoma in relation to whole bodv naevus counts
OR2 (95%CI1
adjustedfor OR3 95%CI,
Nvo. of Cases Controls numbers of atYpical adjustedfor
naevi No. 0%0 No. %o OR] (95%CII naevi skin type
0-4 33 (8) 45 (11) 1.0 1.0 1.0
5-9 35 (8) 54 (13) 0.9 (0.5- 1.7) 0.8 (0.4- 1.5) 1.0 (0.5- 1.9)
10-24 97 (23) 138 (33) 1.1 (0.6- 1.9) 1.0 (0.6- 1.8) 1.3 (0.7 -2.3)
25-49 92 (22) 92 (22) 1.9 (1.1-3.5)* 1.6 (0.9-3.0) 2.8 (1.5-5.1)**
50-99 92 (21) 64 (15) 3.2 (1.7-5.8)*** 2.2 (1.2-4.2)* 4.2 (2.2-7.9)***
> 100 77 (18) 23 (6) 7.7 (3.8-15.8)*** 3.1 (1.4-6.7)** 9.1 (4.4- 18.6)***
Trend test *P<0.05. $$ <0.01. $$P<0.001. ORI odds ratiosadjusted for age. sex and examiner. OR2 odds ratiosadjusted forage. sex, examiner
and number ofatypical naevi. OR3. odds ratios adjusted for age. sex, examiner and skin type. Trend in risk for increasing numbers of common
naevi: for OR I =56.2. P<0.0001: for OR2 ZvI = 18.9. P<0.0001; for OR3 ,l =64.7. P<0.0001.
This trend remained highly significant after adjustment for
15 30 45
Age (years)
the number of common naevi and skin type.
Table IV shows the relative risk of melanoma in relation
to the numbers of common and atypical naevi with
significant trends in risks with increasing numbers. as
expected after adjustments in the previous tables. Atypical
naevi were found to be more common in male cases. of
whom 33% had any atypical naevi compared with 22% of
the females (not in table). Atypical naevi were also more
prevalent in cases with red or blonde hair than in those with
brown or black hair colour (X2 = 11.1. P=0.01) but this
association was not found for controls (X-1=0.5. P=0.5).
Atypical naevi were associated with fair skin types in cases
and controls combined (X2' = 5.5. P=0.02). Atypical naevi
were associated with multiple primary melanoma and of the
four cases. two had four or more atypical naevi (OR=9.0:
60 75 P=0.55).
Figure 1 Average naevus counts bv age in cases (top curve) and
controls (bottom curve).
or above compared with 6% of the controls [odds ratio of 7.7
(95% CI 3.8-15.8) compared with 0-4 naevi]. When the
odds ratios were adjusted for the number of atypical naevi
and skin type, the trend in risk remained highly significant.
The numbers of naevi decreased with age in both cases and
controls. The distribution of naevi by age in cases and
controls is shown in Figure 1. There were no substantial
differences in the total body naevus count between the sexes.
There was no correlation between skin type and total naevus
count in either cases or controls.
Atypical naevi
Four or more clinically atypical naevi were found in 10% of
the cases and 10% of the controls, giving an odds ratio of 28.7
(95% CI 8.6-95.6) when compared with subjects with no
atypical naevi. A highly significant trend was found with
increasing numbers of atypical naevi (P<0.0001) (Table III).
Risk of melanoma associated with naevi on unusual sites
A highly significant trend in risk was found for increasing
numbers of naevi on the dorsum of the feet (P<0.0001) and
on the buttocks (P=0.0001) (Table V). Both of these trends
remained highly significant after adjusting for the number of
atypical naevi. Scalp naevi were also more frequent among
cases: 10% of the cases had one or more scalp naevi
compared with 300 of the controls. with an odds ratio of 2.4
(95% CI 1.4-4.2). The trend for increasing numbers of scalp
naevi was significant (Table V).
Pigmented lesions of the iris
One or more pigmented lesions of the iris were found in 20%
of the cases and 12% of the controls, with an odds ratio of
1.7 (95% CI 1.2-2.6) and the trend for increasing numbers
was significant (x2 =7.14. P=0.007).
AMS score
The risk of melanoma increased steadily with increasing
AMS score. with a highly significant trend (P<0.0001)
(Table VI). This trend remained highly significant after
Table m Risk of melanoma in relation to the number of atypical naevi
OR2 (95%CI1
No. of adjustedfor OR3 950CI,
atypical Cases Controls numbers of common adjusted for
naevi No. 0%0 No. (0% OR] (95%CI) naevi skin type
0 313 (74) 389 (94) 1.0 1.0 1.0
1 41 (10) 16 (4) 3.9 (2.1 -7.3)** 3.0 (1.6-5.7)*** 3.5 (1.9-6.6)***
2- 3 28 (7) 8 (2) 5.3 (2.3- 12.1)*** 2.9 (1.2-7.0)* 5.4 (2.3- 12.4)***
.4 44 (10) 3 (1) 28.7 (8.6-95.6)*** 14.3 (4.1-50.0)*** 23.7 (7.1-78.9)***
*P<0.05. **P<0.01. ***P<0.001. ORI odds ratios adjusted for age, sex and examiner. OR2 odds ratios adjusted for age. sex. examiner and
number ofcommon naevi. OR3 odds ratios adjusted for age. sex. examiner and skin type. Trendin risk forincreasingnumbers ofatypicalnaevi: for
ORI
= 57.7. P<0.0001: for OR2 /1 29.4. P<0.0001; for OR3 j =52.7. P<0.0001.
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Table IV Relative risks of melanoma in relation to the numbers of
common and atypical naevi
Numbers of Numbers ofatypical naevi Z-testfor trend
common naevi 0 1 2 (P-value)
0-24 1.0* 5.9 5.5 2.86
(n=389) (n= 10) (n=3) (P=0.004)
25-49 1.8 6.5 2.0 1.56
(n= 158) (n= 18) (n=8) (P=0.12)
50-99 2.4 5.6 12.0 2.95
(n= 115) (n= 16) (n=25) (P=0.003)
)100 2.6 6.2 53.5 3.65
(n=40) (n= 13) (n=47) (P=0.0003)
Z-test 4.35 4.006 2.86
for trend (P= <0.0001) (P= 1.0) (P=0.004)
(P-value)
*Odds ratios.
adjustment for atypical naevi and skin type. There was no
evidence for a threshold to indicate a dichotomous trait.
Sixteen per cent of the cases scored three or more on the
AMS scoring system compared with 2% of the controls: odds
ratio 10.4 (95% CI 5.0-21.5). The AMS phenotype was more
prevalent among male cases (23%) than female cases (11%)
and the mean age of AMS cases was 46 years vs 52 in non-
AMS cases (P=0.003). There was no statistical difference in
melanoma thickness between AMS and non-AMS cases.
Sex and the risk associated with naevi
Table VII shows the relative risk for various naevus
characteristics in males and females. Although the odds
ratio for 100 or more common naevi (compared with 0-9)
was different in males and females, formal tests showed that
this difference was not statisically significant (difference in
slopes between the effect of common naevi in males and
females, X21=2.65, P=0.10 and the test for the interaction
with the grouping as shown, X23=5.13, P=0.16). There was
no difference between the odds ratios assocated with the
numbers of atypical naevi and AMS scores in males and
females (Table VII).
Attributable proportions and interaction with age
Table VIII shows the odds ratios and the attributable
proportions by age for several features of the naevus
phenotype. The presence of 100 or more naevi accounted
for 28% of melanomas below the age of 40 and 15% at age
40 and above. A total of 26% and 14% of the melanomas at
these ages were attributable to the presence of two or more
atypical naevi. Similar attributable proportions were found
for the presence of the AMS phenotype. Skin type 1
accounted for only 9% of the melanomas.
Dicssion
The results of this study were adjusted for age, sex, and
examiner. There was no significant difference between cases
and controls in social class, and general practitioner and
hospital controls were also comparable in this respect. There
were more controls in the younger age groups compared with
cases but all the results had been adjusted for age. There was
no statistical differences in the naevus count variables
between hospital and general practitioner controls and the
results have therefore been pooled for the two groups.
Regarding interobserver variability, when the analyses were
performed for cases and controls seen by each examiner
separately, the odds ratios were of the same magnitude and
always in the same direction. Interobserver variability was
formally assessed with double mole counting in 19 individuals
with good agreement between the two examiners (correlation
coefficient, 0.966). The results of this study were adjusted for
examiner so this was unlikely to be a significant confounder.
There was a difference in the thickness of melanoma between
responders (mean thickness 1.4 mm) and non-responders
(3.9 mm) but this is unlikely to influence the naevus data
and there was no correlation between numbers of atypical
naevi or the AMS phenotype and melanoma thickness in the
responders.
Several case-control studies of melanoma have reported
on whole body naevus counts performed by trained
examiners e.g. Swerdlow et al. (1986), Grob et al. (1990),
Table V Risk ofmelanoma in relation to the numbers ofcommon and atypical naevi on the dorsum of the feet. buttocks
and anterior scalp
OR2 (95%CI}
adjustedfor
Cases Controls numbers ofatypical
No. (%) No. (O) OR] (95%CI} naevi
No. of naevi on
dorsum of feet
0 305 (72) 360 (87) 1.0 1.0
1 52 (12) 34 (8) 2.1 (1.3-3.4)** 1.7 (1.0-2.9)*
2 32 (8) 14 (3) 3.6 (1.8-7.2)*** 2.8 (1.3-6.0)**
3 14 (3) 2 (1) 8.6 (1.9-39)** 5.9 (1.2-27.9)*
,>4 23 (5) 6 (1) 5.0 (1.9- 12.9)*** 2.2 (0.8-6.0)
No. of naevi on
buttocks
0 269 (63) 333 (80) 1.0 1.0
1 92 (22) 49 (12) 2.3 (1.6-3.5)*** 2.1 (1.4-3.2)***
2 30 (7) 23 (6) 1.8 (1.0-3.2)* 1.1 (0.6-2.0)
4 21 (5) 7 (2) 4.2 (1.7- 10.2)** 0.8 (0.2-4.0)
,>4 14 (3) 4 (1) 4.7 (1.5-14.8)** 2.7 (0.8-9.8)
No. of naevi on
anterior scalp
0 383 (90) 393 (94) 1.0 1.0
1 21 (5) 17 (4) 1.5 (0.7-2.9) 1.1 (0.5-2.4)
2 8 (2) 1 (0) 12.0 (1.4-98.6)* 7.8 (0.8-72.3)
. 3 14 (3) 5 (1) 3.4 (1.2-9.8)* 1.9 (0.6-6.0)
*P<0.05.**P<0.01. **P<0.001. Trend for increasing numbers of naevi on the dorsum of the feet: for OR1 I =31.7,
P<0.0001; for OR2 x2 = 12.6, P=0.0004. Trend for increasing numbers of naevi on the buttocks: for ORI >1 =25.9,
P<0.0001; for OR2ri=8.1, P=0.005. Trend for increasing numbers of naevi on the anterior scalp: for ORI 7) = 10.6.
P=0.001; for OR2 rI =2.8. P=0.09.Rik of oae meanma
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Table VI Risk of melanoma in relation to AMS score
0R2(95%CIl
adjustedfor OR3(95%CI)
AMS Cases Controls numnbers of atipical adjustedfor
score No. (%) No.(O OR](950%CI naevi skin tVpe
0 163 (38) 253 (61) 1.0 1.0 1.0
1 126 (30) 119 (29) 1.7 (1.2-2.3)** 1.5 (1.1 -2.2)* 1.7 (1.2-2.4)**
2 68 (16) 35 (8) 3.2 (2.0-5.2)*** 2.4 (1.4-3.9)*** 3.3 (2.0-5.3)***
3 47 (11) 8 (2) 10.8 (5.0-24.0)*** 4.1 (1.7- 10.3)** 10.0 (4.5-22.1)***
4&5 22 (5) 1 (0) 36.7 (4.8-282.8)*** 10.1 (1.2-85.5)* 38.0 (4.9-292.7)***
*P<0.05. *P<0.01. ***P<0.001. Trend test forincreasing AMS score. forORI 1 =70.4,P<0.0001; for0R2 I =25.4, P<0.0001; for0R3
X2I=71.8, P<0.0001.
The AMS scoring system. Patients are said to have the AMS phenotype if they score 3 or more
Naevus variables Score
>,100 naevi if aged 20-50 1
or .50 naevi if <20 years of age
or > 50 years of age
2 or more clinically atypical naevi 1
1 naevi on the buttocks or 1
>2 naevi on the dorsum of the feet
1 naevi on the anterior scalp 1
1 pigmented lesions of the iris
Maximum score 5
Table VII Risk of melanoma in relation to numbers of naeVi, according to sex
M4ales Females
OR 95%CI OR 95%CI
Number of common naevi
0-9 1 1
10-49 1.8 (1.0- 3.3) 1.) (0.7-2.1)
50-99 3.2 (1.6-6.5)** 3.0 (1.6-5.7)**
> 100 14.4 (5.7-36.3)*** 4.0 (1.8 -8.9)***
Chi-squared test for the difference in trends between males and females: X1=2.65. P=0.10.
Number of atypical naeVi
0 1 1
1 -2.9 (1.1 -7.5)* 4.8 (2.1 - 11.1)***
>2 9.7 (4.1-23.0)*** 11.3 (3.8-36.6)***
Chi-squared test for the difference in trends between males and females: j-=0.40. P=0.53.
AMS score
0 1 1
1 1.5 (0.9-2.6) 1.8 (1.2-2.7)**
4.9 (2.3- 10.4)*** 2.5 (1.3-4.5)**
3 15.5 (4.4-54.6)*** 6.8 (2.5- 19.1)***
4&5 29.5 (3.7-234.7)*** (2.1 x)**
Chi-squared test for the difference in trends between males and females: x - 1.9. P=0.17.
*P<0.05. **P<0.01. ***P<0.001.
Table VIII Odds ratios and attributable proportions of melanoma in relation to phenotypical features
Prevalence Odds ratio Attributable propor-
in cases (O} (95% CIJ tion
(95% CIl
One hundred or more naeVi
(relative to less than 100)
Aged less than 40 28 4.4 (2.1-9.0) 22% (80/o-64%)
Aged more than 40 15 4.5 (2.1-9.4) 12% (5%-32%)
Two or more AN
(relative to less than 2)
Aged less than 40 26 9.2 (3.6-22.4) 23% (12%0-43%)
Aged more than 40 14 10.8 (3.8-30.9) 13% (4%-42%)
AMS score of .3
(relative to less than 3)
Aged less than 40 21 16.1 (4.6- 57.5) 20% (50°-82%)
Aged more than 40 15 6.9 (2.9-16.6) 13% (4%-36%)
Skin type I
All ages 12 3.2 (1.8-5.7) 9% (40/o-21%)
Skin type I or II
and two or more
atypical naevi
All ages 7 5.3 (2.8-20.5) 6°io (2/o-190o)PRi* Of c ubr_ ol
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Augustsson et al. (1991) and Garbe et al. (1994) in Europe;
Holly et al. (1987) in the USA and Nordlund et al. (1985) in
Australia. In these studies, atypical or large numbers of
common naevi were the strongest risk factor for melanoma
with relative risks of the order of 10 for two or more atypical
naevi. Whereas numbers ofnaevi are strongly associated with
melanoma, less is known about the importance of the
distribution of naevi in melanoma. Many studies have
looked at sites such as the arms but there is little data on
non-sun-exposed sites. Grob et al. (1990) reported that naevi
on the buttocks were an important risk factor for melanoma
cases with an odds ratio of 10.9 for five or more buttocks
naevi. In one UK study, melanoma cases were more likely to
have any naevi on the scalp than controls though their
number (beyond one) were not counted (Swerdlow et al.,
1986). Nordlund et al. (1985) found atypical naevi on non-
sun-exposed sites such as the buttocks, the feet and the toe
webs in melanoma cases in Australia, but the naevus counts
at different body sites were not formally compared between
cases and controls.
The presence of many atypical naevi was strongly
associated with melanoma in the study reported here as
were large number of common naevi. Naevus counts
decreased with age in both cases and controls but older
cases were more likely to have a large number of naevi than
age-matched controls. The observation that the naevus count
decreases with age is based on cross-sectional studies and it is
not known to what extent this is owing to a tendency to
larger numbers of naevi among more recent birth cohorts
(Halpern et al., 1993). Atypical naevi were also found less
commonly in the older study subjects. The proportion of
melanoma attributable to the presence of two or more
atypical naevi decreased with age; it accounted for a quarter
ofall melanomas below the age of40 compared with 14% for
the cases aged 40 years or above. A similar decrease in the
aetiological fraction with age was seen for numbers of
common naevi: 100 or more common naevi accounted for
nearly twice as many melanomas in the cases aged below 40
years of age compared with cases older than 40. The
differences in relative risk by age for naevus-related variables
in our data may in part account for the differences in relative
risks for these naevus variables between studies, which will
have different weighting by age group in their all-age results.
It is not clear why atypical naevi and common naevi were
more common in male than female cases and controls though
melanoma is twice as common in females than males in the
UK. The risk ofmelanoma associated with a large number of
atypical naevi, however, was similar in each sex.
In this study, individuals with red hair or fair skin type
were more likely to have atypical naevi. Weinstock et al.
(1991) have reported that atypical naevi were more common
in individuals with poor tanning ability. It is possible that
atypical naevi are more easily expressed in individuals with
fair skin because oftheir increased susceptibility to ultraviolet
radiation. The presence of atypical naevi was associated with
multiple melanoma primaries and this is consistent with
observations in familial melanoma studies (Greene et al.,
1985).
Naevi on unusual sites (dorsum of the feet, buttocks and
anterior scalp) were risk factors for melanoma and remained
significant after adjustment for atypical naevi. Iris naevi were
associated with melanoma in this study. Rodriguez-Sains et
al. (1986) reported that patients with AMS often had many
iris naevi and suggested that their presence could be a marker
of an expanded melanocytic system with numerous naevi
found on the skin and in the eye. Albert et al. (1983) and
Nordlund et al. (1985) had previously found that iris naevi
were more common in cutaneous melanoma patients than in
controls, although the numbers in the first study were small.
This study is the first to determine the risk of melanoma
associated with the AMS phenotype in the general population
rather than in the context of families at high risk. We used a
scoring system for the AMS phenotype designed by ourselves,
as there is no international agreement on the definition of this
phenotype. This scoring system was originally designed for
our family studies of melanoma (Newton et al., 1994). The
AMS phenotype is thought to be a marker of a genetic
susceptibility to melanoma, but sun exposure may influence
the expression of this phenotype. There has been some
controversy in the literature whether the AMS phenotype is a
dichotomous or continuous phenotype (Traupe et al., 1989).
The results of the present study favour a continuous
phenotype, as the risk of melanoma increased with
increasing AMS score. This would not favour the presence
of a single autosomal dominant gene for the expression of
this phenotype and it is more likely that several susceptibility
genes are involved with the interaction of sun exposure or
other environmental factors.
Thirty-two per cent and 16% of all melanomas in this
study were attributable to an AMS score of 2 or 3
respectively and these aetiological fractions decreased with
age. Among the five clinical features of the AMS phenotype
scoring system, the presence of two or more atypical naevi
yielded the highest relative risk but other clinical features of
the phenotype were independently associated with an
increased risk. None of these naevus characteristics were
responsible for more than a quarter of all melanomas and it
may be that for screening programmes in countries with a
low incidence of melanoma, stronger predictors will be
needed. However, by screening younger age groups, the
AMS phenotype may have a role in the secondary prevention
of melanoma.
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